H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. | 2 | $98,288 | $90,000 - $106,575 | 100.0% |
| Takeda Development Center Americas, Inc. | 2 | $117,244 | $115,523 - $118,965 | 50.0% |
| BioMarin Pharmaceutical Inc. | 1 | $131,805 | $131,805 - $131,805 | 100.0% |
| BIOVERATIV THERAPEUTICS, INC. | 1 | $159,744 | $159,744 - $159,744 | 0.0% |
| Sarepta Therapeutics, Inc. | 1 | $190,000 | $190,000 - $190,000 | 100.0% |
| ULTRAGENYX PHARMACEUTICAL, INC. | 1 | $168,917 | $168,917 - $168,917 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Director | 4 | $164,331 | $131,805 - $190,000 |
| Senior | 4 | $111,049 | $90,000 - $118,965 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Cambridge | MA | 3 | $118,965 |
| Boston | MA | 1 | $90,000 |
| Novato | CA | 1 | $168,917 |
| Oak Ridge | NC | 1 | $106,575 |
| San Rafael | CA | 1 | $131,805 |
| Waltham | MA | 1 | $159,744 |
These roles are variations of Senior Associate, Regulatory CMC with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Senior Associate, Regulatory CMC | 5 | $106,160 | |
| Associate Director, Regulatory CMC | 4 | $162,617 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 2 | $164,331 | 50.0% |
| 2022 | 1 | $131,805 | 100.0% |
| 2023 | 2 | $140,000 | 100.0% |
| 2024 | 1 | $106,575 | 100.0% |
| 2026 | 2 | $117,244 | 50.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. | 2 | $98,288 | 100.0% |
| Takeda Development Center Americas, Inc. | 2 | $117,244 | 50.0% |
| BioMarin Pharmaceutical Inc. | 1 | $131,805 | 100.0% |
| BIOVERATIV THERAPEUTICS, INC. | 1 | $159,744 | 0.0% |
| Sarepta Therapeutics, Inc. | 1 | $190,000 | 100.0% |